Evidence map›Paper›PMID 35725494›Full record

ArticleTrials2022

Parasternal After Cardiac Surgery (PACS): a prospective, randomised, double-blinded, placebo-controlled trial study protocol for evaluating a continuous bilateral parasternal block with lidocaine after open cardiac surgery through sternotomy.

Mark Larsson, Ulrik Sartipy, Anders Franco-Cereceda, Anders Öwall, Jan Jakobsson

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mark LarssonDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. mark.larsson@ki.se.ORCID http://orcid.org/0000-0002-0361-1013
Ulrik SartipyDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Anders Franco-CerecedaDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Anders ÖwallDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Jan JakobssonInstitution for Clinical Sciences, Karolinska Institutet at Danderyds Hospital, Stockholm, Sweden.
Karolinska University Hospital · SEDanderyds sjukhus · SE

Funding

Grünenthal Sweden AB 2-2191/2020Hjärt-Lungfonden 20190533
6 · The paper itself

Abstract

backgroundMultimodal analgesia that provides optimal pain treatment with minimal side effects is important for optimal recovery after open cardiac surgery. Regional anaesthesia can be used to block noxious nerve signals. Because sternotomy causes considerable pain that lasts several days, a continuous nerve block is advantageous. Previous studies on continuous sternal wound infusion or parasternal blocks with long-acting local anaesthetics have shown mixed results. This study aims to determine whether a continuous bilateral parasternal block with lidocaine, which is a short-acting local anaesthetic that has a favourable safety/toxicity profile, results in effective analgesia. We hypothesise that a 72-hour continuous parasternal block with 0.5% lidocaine at a rate of 7 ml/hour on each side provides effective analgesia and reduces opioid requirement. We will evaluate whether recovery is enhanced.

methodsIn a prospective, randomised, double-blinded manner, 45 patients will receive a continuous parasternal block with either 0.5% lidocaine or saline. The primary endpoint is cumulated intravenous morphine by patient-controlled analgesia at 72 hours. Secondary end-points include the following: (1) the cumulated numerical rating scale (NRS) score recorded three times daily at 72 hours; (2) the cumulated NRS score after two deep breaths three times daily at 72 hours; (3) the NRS score at rest and after two deep breaths at 2, 4, 8 and 12 weeks after surgery; (4) oxycodone requirement at 2, 4, 8 and 12 weeks after surgery; (5) Quality of Recovery-15 score preoperatively compared with that at 24, 48 and 72 hours, and at 2, 4, 8 and 12 weeks after surgery; (6) preoperative peak expiratory flow compared with postoperative daily values for 3 days; and (7) serum concentrations of interleukin-6 and lidocaine at 1, 24, 48 and 72 hours postoperatively compared with preoperative values. DISCUSSION: Adequate analgesia is important for quality of care and vital to a rapid recovery after cardiac surgery. This study aims to determine whether a continuous parasternal block with a short-acting local anaesthetic improves analgesia and recovery after open cardiac procedures.

trial registrationThe study was registered in the European Clinical Trials Database on 27/9/2019 (registration number: 2018-004672-35).

Indexed as

Cardiac Surgical ProceduresLidocaineAnalgesics, OpioidAnesthetics, LocalHumansPain MeasurementPostoperative PainProspective StudiesRandomized Controlled Trials as TopicSternotomyAnalgesics, OpioidAnesthetics, LocalLidocaineLidocaineOpen cardiac surgeryParasternal blockPostoperative painRecoverySternotomy

Identifiers

PMID35725494
PMCPMC9208208
OpenAlexW4283162533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.